How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort
Kübra Öztürk(Istanbul Medeniyet University), Erbil Ünsal(Dokuz Eylül University), Hafize Emine Sönmez(Center for Rheumatology), Belde Kasap Demir(Izmir Kâtip Çelebi University), Nuray Aktay Ayaz, Mustafa Çakan(Zeynep Kamil Hospital), Semanur Özdel(Ministry of Health), Selçuk Yüksel(Pamukkale University), Balahan Makay(Dokuz Eylül University), Fatma Gül Demirkan(Istanbul University), Gülşah Kılbaş(Pamukkale University), Hatice Adıgüzel Dundar(Izmir University), Mukaddes Kalyoncu(Karadeniz Technical University), Hakan Kısaoğlu(Karadeniz Technical University), Deniz Gezgin Yıldırım(Gazi University), Sara Şebnem Kılıç(Bursa Uludağ Üni̇versi̇tesi̇), Gülçin Otar Yener(Eskişehir City Hospital), Gülcan Özomay Baykal(Ümraniye Eğitim ve Araştırma Hastanesi), Serkan Türkuçar(Pamukkale University), Esra Bağlan(Ministry of Health), Sevcan A. Bakkaloğlu, Betül Sözeri(Ümraniye Eğitim ve Araştırma Hastanesi), Tuncay Aydın(Dokuz Eylül University), Hülya Köse(Dicle University)
Cited by 3
Related Papers
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations
|The American Journal of Human Genetics|2008|307
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
|The Lancet Child & Adolescent Health|2019|214
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis
|Annals of the Rheumatic Diseases|2019|109
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
|Journal of Clinical Immunology|2021|77
Schimke immunoosseous dysplasia: suggestions of genetic diversity
|Human Mutation|2006|64